BACKGROUND: A 73-year-old patient presented in our clinic with multiple pigmented iris nodules in the left eye. Though asymptomatic, there was a reported increase in size and number of the nodules during the past year. METHODS: Interventional case report describing a biopsy-proven multifocal iris melanoma treated with a palladium-103 plaque to include the entire anterior chamber within the targeted zone. Biopsy was performed utilizing a 25-gauge aspiration-cutter under viscoelastic. The cornea was protected during radiation therapy with the amniotic membrane buffer technique. Evaluation parameters included visual acuity and clinical assessments aided by slit-lamp photography as well as high-frequency ultrasound imaging. RESULTS: Plaque radiation therapy was well tolerated. Her visual acuity has remained within five letters at 20/25 at 1-year follow-up. Clinical evaluation revealed no evidence of corneal epitheliopathy, iris neovascularization, or visually significant cataract. High-frequency ultrasound imaging revealed a 15% reduction of the tumor's height. Serial abdominal imaging revealed no metastatic uveal melanoma. CONCLUSIONS: We present a biopsy-proven iris diffuse melanoma treated with palladium-103 plaque radiation therapy. Though the entire anterior segment was irradiated, there were no significant side-effects. Local tumor control was excellent during the first postoperative year.
BACKGROUND: A 73-year-old patient presented in our clinic with multiple pigmented iris nodules in the left eye. Though asymptomatic, there was a reported increase in size and number of the nodules during the past year. METHODS: Interventional case report describing a biopsy-proven multifocal iris melanoma treated with a palladium-103 plaque to include the entire anterior chamber within the targeted zone. Biopsy was performed utilizing a 25-gauge aspiration-cutter under viscoelastic. The cornea was protected during radiation therapy with the amniotic membrane buffer technique. Evaluation parameters included visual acuity and clinical assessments aided by slit-lamp photography as well as high-frequency ultrasound imaging. RESULTS: Plaque radiation therapy was well tolerated. Her visual acuity has remained within five letters at 20/25 at 1-year follow-up. Clinical evaluation revealed no evidence of corneal epitheliopathy, iris neovascularization, or visually significant cataract. High-frequency ultrasound imaging revealed a 15% reduction of the tumor's height. Serial abdominal imaging revealed no metastatic uveal melanoma. CONCLUSIONS: We present a biopsy-proven iris diffuse melanoma treated with palladium-103 plaque radiation therapy. Though the entire anterior segment was irradiated, there were no significant side-effects. Local tumor control was excellent during the first postoperative year.
Authors: Bertil Damato; Andrzej Kacperek; Mona Chopra; Martin A Sheen; Ian R Campbell; R Douglas Errington Journal: Int J Radiat Oncol Biol Phys Date: 2005-09-01 Impact factor: 7.038
Authors: L Lumbroso-Le Rouic; S Delacroix; R Dendale; C Levy-Gabriel; L Feuvret; G Noel; C Plancher; C Nauraye; P Garcia; V Calugaru; B Asselain; L Desjardins Journal: Eye (Lond) Date: 2006-11-18 Impact factor: 3.775
Authors: Carol L Shields; Masood Naseripour; Jerry A Shields; Jorge Freire; Jacqueline Cater Journal: Am J Ophthalmol Date: 2003-05 Impact factor: 5.258
Authors: Julie R Bloom; Alexandra G Castillejos; Brianna Jones; Nimesh Patel; Barry S Rosenstein; Richard G Stock Journal: Radiat Oncol Date: 2022-05-17 Impact factor: 4.309
Authors: Wu Liu; Jenna May Kim; Benjamin K Young; Ravinder Nath; Zhe Chen; Roy H Decker; Melvin A Astrahan; Renelle Pointdujour-Lim Journal: Ocul Oncol Pathol Date: 2018-10-11